In colon cancer, it was reported that overexpression of DDX5 upregulates the levels of the AKT protein and mRNA, increasing the transcription of the AKT gene promoter by DDX5 itself, β-catenin and NF-κB [62,63]. The gene discussed is AKT1; the disease is malignant colon neoplasm.